US · Healthcare · Medical Care Facilities
EPS came in at 0.60 against a street estimate of 0.46 — a beat of 30.4%.
Analysts rate Acadia Healthcare Company Inc a buy (8 buy, 5 hold, 1 sell out of 14) with an average price target of $33.79.
CONFIDENT Acadia delivered Q2 revenue flat YoY but +2.8% normalized; new beds ramping ahead of plan. Raised FY26 EBITDA guidance midpoint to $602.5M. Strong free cash flow of $124M; debt reduced $113M. Q2 2026 Geographic data not granularly disclosed; NY Medicaid headwind on Pennsylvania highlighted as specific drag. Analysts pressed on $200M bed cohort progress (confirmed ahead of plan), revenue-per-day decline (service mix explained), and PLGL litigation risk (current-year in line, prior-year settled). Management emphasized operational discipline, payer collaboration, and outcome-based advocacy. 2026-07-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 16.07% |
| Wellington Management Company LLP | 6.15% |
| Vanguard Portfolio Management, LLC | 5.77% |
| FMR Inc | 5.39% |
| Carronade Capital Management LP | 5.12% |
| Morgan Stanley - Brokerage Accounts | 4.87% |
| Deerfield Management Co | 4.86% |
| Farallon Capital Management, L.L.C. | 4.53% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $895,309 thousand, up from $851,573 thousand in the third quarter of 2025. • Nine-month 2026 reven | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter revenue was $895.3 million, up 5.1% from $851.6 million in the prior-year period. • Reported net income attributabl | 2026-11-04 |
| Company announcement · Q3 2026 ACADIA HEALTHCARE COMPANY, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Settlement Approval Date: September 1, 2026 – U.S. District Court for the Midd | 2026-09-25 |
| Quarterly report · Q2 2026 ACADIA HEALTHCARE COMPANY, INC. — 10-Q SUMMARY For Quarterly Period Ended June 30, 2026 --- HEADLINE NUMBERS • Q2 2026 Revenue: $865.8 million (Q2 | 2026-07-28 |
| Results announced · Q3 2026 ACADIA HEALTHCARE Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Revenue: $865.8 million in Q2 2026, flat vs. $869.2 million in Q2 2025; normalized grow | 2026-07-28 |
| Company announcement · Q2 2026 ACADIA HEALTHCARE COMPANY, INC. – 8-K SUMMARY HEADLINE NUMBERS • Jury verdict issued May 12, 2026: $35 million in compensatory damages and $70 milli | 2026-05-18 |
| Shareholder vote results · Q2 2026 ACADIA HEALTHCARE COMPANY, INC. – 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held May 6, 2026 • Company trades on NASDAQ under ticker | 2026-05-06 |
| Quarterly report · Q1 2026 ACADIA HEALTHCARE COMPANY, INC. – FORM 10-Q SUMMARY Quarter Ended March 31, 2026 --- HEADLINE NUMBERS • Revenue (Q1 2026): $828.8 million vs. $770. | 2026-04-30 |
Readable in the app.
| Announcement | Date |
|---|---|
| Full-year 2026 financial guidance raised Acadia Healthcare reported a solid third quarter, with revenue of $895.3 million, up 5.1% from a year earlier. Same-facility revenue rose 5.2%, supported by 1.1% higher patient days and a 4. | 2026-11-04 |
| Second quarter 2026 results and full year financial guidance updated Acadia Healthcare reported Q2 2026 results showing significant earnings deterioration despite flat revenue. Revenue totaled $865.8 million, essentially unchanged from $869.2 million in Q2 20 | 2026-07-28 |
| Increases full year 2026 adjusted EBITDA and adjusted EPS guidance Acadia Healthcare reported first-quarter 2026 results with solid revenue growth of 7.6% to $828.8 million, driven by increased patient volumes and higher revenue per patient day. Key highlig | 2026-04-29 |
| Q4 2025 results and 2026 full year financial guidance provided Acadia Healthcare reported mixed results for Q4 2025 and full year 2025. Revenue grew 6.1% to $821.5 million in Q4 and 5.0% to $3.31 billion for the year, beating guidance. However, profitab | 2026-02-25 |
| 2025 Adjusted EBITDA and EPS guidance reduced due to PLGL reserves Acadia Healthcare, the largest standalone behavioral healthcare company in the U.S., significantly lowered its 2025 financial guidance following an annual actuarial review of professional an | 2025-12-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Acadia Healthcare Company Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.